Myocardial extracellular volume assessment at CT in hospitalized COVID-19 patients with regards to pulmonary embolism

[1]  Yuchuan Wang,et al.  Why Omicron Variant of SARS‐CoV‐2 is Less Fatal? , 2022, Chembiochem : a European journal of chemical biology.

[2]  A. Sinusas,et al.  Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity , 2022, Frontiers in Cardiovascular Medicine.

[3]  W. Auffermann,et al.  Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta, Omicron variants and vaccines , 2022, Emergency Radiology.

[4]  V. Novakovic,et al.  Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation , 2022, Frontiers in Cellular and Infection Microbiology.

[5]  Matthew W. Martinez,et al.  2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play , 2022, Journal of the American College of Cardiology.

[6]  B. Cowling,et al.  Omicron severity: milder but not mild , 2022, The Lancet.

[7]  O. Geier,et al.  Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism , 2021, International journal of cardiology. Heart & vasculature.

[8]  M. V. Van Kerkhove COVID-19 in 2022: controlling the pandemic is within our grasp , 2021, Nature Medicine.

[9]  E. Poveda,et al.  Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study , 2021, Scientific Reports.

[10]  Cheuk-Kwan Sun,et al.  Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis , 2021, Scientific Reports.

[11]  Ari I. Jonisch,et al.  Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study , 2021, Radiology.

[12]  A. Mebazaa,et al.  Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome , 2021, European heart journal.

[13]  H. Yabuuchi,et al.  Right Ventricular Extracellular Volume with Dual-Layer Spectral Detector CT: Value in Chronic Thromboembolic Pulmonary Hypertension. , 2021, Radiology.

[14]  D. Gopalan,et al.  Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19 , 2020, The Lancet Respiratory Medicine.

[15]  A. Sironi,et al.  Computed tomography-derived myocardial extracellular volume: an early biomarker of cardiotoxicity in esophageal cancer patients undergoing radiation therapy , 2020, Insights into Imaging.

[16]  A. Pollard,et al.  What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 , 2020, The Lancet Infectious Diseases.

[17]  T. Kwee,et al.  Chest CT in COVID-19: What the Radiologist Needs to Know , 2020, Radiographics : a review publication of the Radiological Society of North America, Inc.

[18]  P. Angchaisuksiri,et al.  Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis , 2020, Thrombosis Journal.

[19]  Amit Kj Mandal,et al.  Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications , 2020, The American Journal of Emergency Medicine.

[20]  P. Kellman,et al.  Females have higher myocardial perfusion, blood volume and extracellular volume compared to males – an adenosine stress cardiovascular magnetic resonance study , 2020, Scientific Reports.

[21]  F. Sardanelli,et al.  Assessment of myocardial extracellular volume on body computed tomography in breast cancer patients treated with anthracyclines. , 2020, Quantitative imaging in medicine and surgery.

[22]  Francesco Sardanelli,et al.  Statistical significance: p value, 0.05 threshold, and applications to radiomics—reasons for a conservative approach , 2020, European Radiology Experimental.

[23]  M. Arrigo,et al.  Pulmonary Embolism and Heart Failure: A Reappraisal , 2020, Cardiac failure review.

[24]  A. Hamdy,et al.  Feasibility of extracellular volume fraction calculation using myocardial CT delayed enhancement with low contrast media administration. , 2020, Journal of cardiovascular computed tomography.

[25]  F. Sardanelli,et al.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis , 2019, European Radiology.

[26]  R. Perez-Johnston,et al.  Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist , 2019, Insights into Imaging.

[27]  Richard B. Thompson,et al.  Myocardial native T1 and extracellular volume with healthy ageing and gender , 2018, European heart journal cardiovascular Imaging.

[28]  G. Krombach,et al.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension , 2017, European Radiology.

[29]  S. Plein,et al.  Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.

[30]  R. Wachter,et al.  Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study , 2016, Journal of Thrombosis and Thrombolysis.

[31]  F. Sardanelli,et al.  Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping. , 2016, European heart journal supplements : journal of the European Society of Cardiology.

[32]  P. Kellman,et al.  Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage , 2015, Journal of the American Heart Association.

[33]  S. Punwani,et al.  Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.

[34]  G. Korosoglou,et al.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.

[35]  Stuart A. Taylor,et al.  Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. , 2013, Radiology.

[36]  Brian A. Nosek,et al.  Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.

[37]  Jianhua Yao,et al.  Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. , 2012, Radiology.

[38]  J. Kline,et al.  Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension. , 2010, Journal of cardiac failure.

[39]  J. Evans Straightforward Statistics for the Behavioral Sciences , 1995 .